Consumer Cyclical
Live Price
Offline$6.83
+3.17% today
1Y Change
-14.32%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Xponential Fitness, Inc. (XPOF) is a Consumer Cyclical stock with a market cap of $250.00M and listed on NYSE. The stock last traded around $6.83 and down 14.3% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -1.7%, EPS growth of +35.2%, a dividend yield of 0.0%. What stands out right now is revenue -1.7%, EPS +35.2%, free cash flow +255.2% with operating margin 6.3% and ROIC 6.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.8. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines XPOF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Cyclical peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XPOF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XPOF Max Drawdown
-61.31%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XPOF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$155.1M
-36.2% YoY
FY Net Income
-$18.8M
-1649.7% YoY
Free Cash Flow
$9.6M
-73.3% YoY
Revenue Growth
-1.7%
EPS Growth
+35.2%
Gross Margin
77.2%
Net Margin
-11.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 315M | 320M | 318M | 243M | 155M |
| Gross Profit | 238M | 261M | 219M | 161M | 101M |
| Operating Income | 80M | -54M | 35M | 13M | -31M |
| EBITDA | 9M | -35M | 71M | 45M | 13M |
| Net Income | -34M | -65M | -4M | 1M | -19M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 46M | 17M | 28M | 32M | 21M |
| Total Assets | 346M | 403M | 529M | 483M | 416M |
| Total Liabilities | 718M | 714M | 617M | 691M | 626M |
| Shareholder Equity | -269M | -217M | -11M | -155M | -654M |
| Total Debt | 525M | 380M | 407M | 170M | 132M |
| Net Debt | 479M | 363M | 379M | 138M | 111M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
14M
-72.2% YoY
Capital Expenditures
5M
+69.9% YoY
Free Cash Flow
10M
-73.3% YoY
Key ratios
Gross Margin
77.2%
Operating Margin
6.3%
Net Margin
-11.1%
ROE
16.8%
Debt / Equity
-1.99x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.